Plasma Levels of Nitrites/Nitrates in Patients with Chronic Atrial Fibrillation are Increased after Electrical Restoration of Sinus Rhythm
Tóm tắt
Introduction: Patients with persistent atrial fibrillation (AF) have hemodynamic changes, which impair endothelial cell function resulting in decreased nitric oxide (NO) production. The aim of this work was to assess endothelial function in AF patients before and at various time points after cardioversion.
Methods: Forty-two patients with AF and 21 normal and age-adjusted healthy controls were studied. Nitrites and nitrates (NO
x
) and von Willebrand factor (vWf) concentrations were measured on blood samples taken just before cardioversion and over a 30 day period after the procedure.
Results: Plasma levels of NO
x
in AF were significantly lower compared to healthy controls (p < 0.001), but after cardioversion gradually increased to approach to those of the healthy controls by the end of the first month of sustained sinus rhythm (p = 0.004). Interestingly plasma levels of NO
x
were negatively correlated to left atrial volume measured by ultrasonography (r = −0.34, p < 0.05). Plasma levels of vWf in AF patients were significantly higher compared to the healthy controls (p < 0.01) but with sustained sinus rhythm decreased (p = 0.02).
Conclusion: The parallel normalization of the NO
x
titers and vWf levels suggests that vascular endothelial function improves after 30 days of normal sinus rhythm.
Tài liệu tham khảo
Lip GYH, Blann AD. Von Willebrand factor: A marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997;34:255–263.
Blann AD, Naqvi T, Waite M, McCollum CN. Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993;13:1674–1678.
Modillo S, Sabatini L, Agricola E, et al. Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation. Int J Cardiol 2000;75:227–232.
Drexler H. Endothelial dysfunction: Clinical implications. Prog Cardiovasc Dis 1997;39:287–324.
Rubanyi GM, Romero JC, Vanhaute PM. Flow-induced release of endothelium relaxing factor. Am J Physiol 1986;250:H1145–H1149.
Buga JM, Gold ME, Fukuto JM, lgnarro LJ. Shear stressinduced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991;17:187–193.
Hutcheson IR, Griffith TM. Release of endotheliumderived relaxing factor is modulated both by frequency and amplitude of pulasatile flow.AmJ Physiol 1991;261:H257–H262. 176 Nikitovic et al.
Noris M, Morigi M, Donadelli R, et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow condition. Circ Res 1995;76:536–543.
Minamino T, Kitakaze M, Sato H, et al. Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol 1997;17:3191–3195.
Minamino T, Kitakaze M, Sanada S, et al. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: Role of nitric oxide. Circulation 1998;98:1721–1727.
Takahashi N, Ishibashi Y, Shimada T, et al. Atrial fibrillation impairs endothelial function of forearm vessels in humans. J Card Fail 2001;7:45–54.
Kanoupakis EM, Manios GE, Mavrakis EH, Kaleboubas DM, Parthenakis IF, Vardas EP. Relation of automatic modulation to reccurence of atrial fibrillation following cardioversion. Am J Cardiol 2000;86:954–958.
Verdon CP, Burton BA, Prior RI. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP when the Griess reaction is used to assay for nitrite. Anal Biochem 1995;224:502–508.
Lip GYH, Lowe GDO, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: Effects of warfarin therapy. Br Heart J 1995;9:527–533.
Moncada S, Palmer R, Higgs E. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109–135.
Zeballos GA, Berstein RD, Thompson CI, et al. Pharmacodynamics of plasma nitrite/nitrate as indication of nitric oxide formation in conscious dogs. Circulation 1995;91:2982–2988.
Kuchan MJ, Frangos JA. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol 1994;266:C628–C636.
Marsden PA, Heng HHQ, Sherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993;307:287–293.
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhari G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265–9268.
Hogman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet 1993;341:1664–1665.
Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 1990;16:377–380.
Kawabata A. Evidence that endogenous nitric oxide modulates plasma fibrinogen levels in rat. Br J Pharmacol 1996;117:236–237.
Freedman JE, Fabian A, Loscalzo J. Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP. Am J Physiol 1995;268:C520–C526.
Li-Saw-Hee FL, Blann AD, Goldsmith I, Lip GYH. Indexes of hypercoagubility measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation. Am J Cardiol 1999;34:255–266.
Lip GYH, Lowe GDO. Fibrin D-dimer: A useful clinical marker of thrombogenesis? 1995;89:205–214.
Li-Saw-Hee FL, Blann AD, Gurney D, Lip GYH. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Eur Heart J 2001;22:1741–1747, doi:10.1053/euhj.2000.2531.
Alt E, Ammer R, Schmitt C, et al. A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J 1997;18:1796–804.
Pedrinelli R, Giampetro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994;344:14–18.
Stehouwer CDA, Nauta JJP, Zeldenrust GP, Hackeng WHL, Donker AJM, den Ottolander GJH. Urinary albumin excretion, cardiovascular disease and endothelial function in non-insulin dependent diabetes mellitus. Lancet 1992;340:319–322.
Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785–1792.
Drexler H. Nitric oxide and coronary endothelial dysfunction in humans. Cardiovasc Res 1999;43:572–579.
Blann AD, Naqvi T, Waite M, McCollum CN. Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertension 1991;17:187–193.
Blann AD, Steele C, McCollum CN. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res 1997;85:433–438.
Greaves M, Pickering C, Knoght G, et al. Changes in factor VIII complex in diabetic ketoacidosis: Evidence of endothelial cell damage? Diabetologia 1987;30:160–166.
Zhang X, Hintze TH. Amplodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent. Circulation 1998;97:576–580.
Grossmann M, Dobrev P, Himmel HM, Kirch W. Local venous reponse to N-dethylamiodarone in humans. Clin Pharmacol Ther2000;67:22–31.